期刊文献+

血清降钙素原在危重患者细菌感染的检测应用

Application of Serum Procalcitonin in Critical Patients with Bacterial Infection
下载PDF
导出
摘要 目的评价血清降钙素原(PET)对危重患者细菌感染诊断的临床价值。方法选择重症监护病房(intensive care unit ICU)中30例细菌感染患者作为感染组,并以30例健康献血者作为对照组,应用免疫比浊法测定其血清PCT及cRP水平,同时作外周血白细胞(WBC)计数,结果作统计分析。结果感染组与对照组比较PCT浓度显著增高(P〈0.01),CRP浓度显著增高(P〈0.05),WBC水平显著升高(P〈0.01);感染组PCT阳性率与血培养阳性率比较明显升高,差异有显著性(P〈0.05),但所有血培养阳性的病例PCT均为阳性,符合率为100%;当感染得到控制后PCT浓度也随之下降。结论血清PCT是危重患者细菌感染的诊断及临床治疗的一个特异性标志物。 Objective To evaluate the clinical value of serum proealcitonin(PCT)in the diagnosis of bacterial infections in the critically ill patients. Methods 30 patients in ICU were chosen as an infected group, their peripheral white blood cells were recorded and the PCT and CRP level in serum were detected by immunoturbidimetry.Another 30 healthy blood donors were chosen as a control group. Results The levels of PCT in bacterial infected group were significantly higher than that in control group( P 〈 0.001 ), so as the levels of CRP( P 〈 0.005) and WBC ( P 〈 0.001 ). In bacterial infected group, the positive rate of PCF was higher than that of hemoeultures( P 〈 0.005),but the positive rate of PCT went up to 100%in the positive hemoettltures. When the infection was under control, the PCT level decreased correspondingly.Conclusion Serum PCT is a specific marker in the diagnosis and therapy of bacterial infections in the critical patients.
出处 《常州实用医学》 2013年第3期158-160,共3页 CHANGZHOU PRACTICAL MEDICINE
关键词 降钙素原 危重患者 细菌感染 proealcitonin Critical Patients bacterial infections
  • 相关文献

参考文献7

二级参考文献58

  • 1时兢,宋秀琴,谢卫星,陆荣国,王烨,衡军锋.降钙素原对脓毒症的早期诊断价值[J].中华检验医学杂志,2004,27(6):385-386. 被引量:26
  • 2葛庆岗,阴赪宏,文艳,吕旌乔,王谊冰.血清降钙素原与多器官功能障碍综合征严重程度相关性的临床研究[J].中国危重病急救医学,2005,17(12):729-731. 被引量:28
  • 3Guerin S.Evaluation of the detection of procalcitonin by an imno chrornatography test:Brahms PET-Q.Ann Biol Clin,2000,58(5):613-614.
  • 4Korppi M,Remes S.Serumprocaleitonin in pneurrgmoccal pnenumonia in children.Eur Respir J,2001,17(4):623-627.
  • 5Giamarellos-Bourboulis EJ,Grecka P,Pouhkou G,et al.Assessmenr of pmcalcitonin as a diagnostic marker of underlying infection in patients with febrile neutropenia.Clin Infect Dis,2001,32(12):1718-1725.
  • 6Maruna P,Nedelnikova K,Gudich R.Physiology and genetics of procalcitonin.Physiol Rev,2000,49:57-61.
  • 7Casado-Flores J,Blaneo-Quiros A.Procalcitonin.:a new marker for bacterial infection.An Esp Pediatr,2001,54(1):69-73.
  • 8Oberhoffer M,Stonans I,Russwerm S,et al.Procalcitonin expression in human peripheral blood mononuclear cells and its modulation by lipopolysacehrides and sepsis-rented cytokines in vitro.J Lab Clin Med,1999,134(1):49-55.
  • 9彭道泉.诊断性试验研究及评价[A].见:赵水平,彭道泉主编.现代临床科研方法学 第1版[C].长沙:中南大学出版社,2001.35.
  • 10NELYN ES, WHANG KT, WHITE JC. Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis [ J ]. Crit Care Med, 1998,26 ( 6 ) :1001.

共引文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部